Stockscreener 앱 받기
2.01
4.69%
0.09
시간 외 거래:
2.04
0.03
+1.49%
Prokidney Corp 주식(PROK)의 최신 뉴스
ProKidney (NASDAQ:PROK) Stock Price Up 7.6%Should You Buy? - MarketBeat
ProKidney Corp (PROK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
3 Promising Penny Stocks With Market Caps Larger Than $200M - simplywall.st
Keep An Eye On ProKidney As Insider Stock Selling Hits US$3.0m - 富途牛牛
ProKidney (PROK) EPS and Revenue: Headline Results Are Close to Consensus; Post-Earnings: The Stock Closes Near UnchangedBanking Earnings Report - vinanet.vn
ProKidney director Brian Pereira sells $1.07 million in shares By Investing.com - Investing.com Canada
ProKidney director Brian Pereira sells $1.07 million in shares - Investing.com
ProKidney (PROK) Quarter in Focus: The Available Figures Are Largely in Line; Post-Report: Shares Fall 4.05% in the Latest ReadingGuidance Update - vinanet.vn
Brian Jg Pereira Sells 229,338 Shares of ProKidney (NASDAQ:PROK) Stock - MarketBeat
ProKidney (NASDAQ:PROK) Director Sells 222,949 Shares - MarketBeat
Prokidney Insider Sold Shares Worth $1,067,773, According to a Recent SEC Filing - marketscreener.com
ProKidney Director Sold Shares Worth Over $1.0M - TradingView
ProKidney (PROK) director sells 757K shares over 3 days - Stock Titan
ProKidney (PROK) Close: Ends Higher by 3.99% at $1.44 at the Close; Immediate View: Support at $1.37 and Resistance at $1.51 Frame the Range under the Current SnapshotHigh Beta Stocks - dars.gov.et
ProKidney (NASDAQ: PROK) director plans new restricted stock sale - Stock Titan
ProKidney (NASDAQ: PROK) director plans sale after trust offloads 229K - Stock Titan
ProKidney (PROK) Latest Reading: Moves 0.71% Lower to $1.39 in the Current Update; Range Context: the Near-Term Reference Band Stretches From $1.32 to $1.46 in Latest TradingFibonacci Entry Signals - vinanet.vn
ProKidney (PROK) Earnings Comparison: Results Show Limited Variance From Forecasts in the Latest Session; Market Follow-Through: The Market Price Declines 0.36% on the DayPost-Earnings Reaction - vinanet.vn
ProKidney: Do-Or-Die Phase 3 Meets A Dwindling Balance Sheet (Rating Downgrade) (PROK) - Seeking Alpha
PROK Q1 2026 Earnings: Narrow EPS Beat Overshadowed by 5% Stock DeclineEarnings Volatility Report - vinanet.vn
What is HC Wainwright's Estimate for ProKidney Q3 Earnings? - MarketBeat
ProKidney Corp. (PROK) Slides 9.3% to $1.46 as Key Support Level Comes into FocusVolume Breakout Ideas - dars.gov.et
Morgan Stanley (PROK) filings show ProKidney stake at 4.7% and below 5% level - Stock Titan
ProKidney (PROK) Gets a Buy from Guggenheim - The Globe and Mail
ProKidney FY2030 EPS Estimate Decreased by HC Wainwright - MarketBeat
ProKidney reports larger second-quarter loss as key clinical trial expenses mount - Winston-Salem Journal
ProKidney earnings missed, revenue topped estimates By Investing.com - Investing.com Nigeria
ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights - The Manila Times
ProKidney earnings missed, revenue topped estimates - Investing.com
ProKidney Corp. (PROK) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
ProKidney completes Phase 3 PROACT 1 accelerated approval enrollment - scanx.trade
ProKidney (NASDAQ:PROK) Releases Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
ProKidney reports Q2 revenue of $150,000 as PROACT 1 advances - Quiver Quantitative
Cell therapy developer ProKidney's Q2 operating loss widens as trial costs rise - TradingView
PROK: Completed key Phase 3 trial enrollment; cash supports operations into mid-2027 - TradingView
ProKidney Corp. (NASDAQ: PROK) warns on cash runway after $89M H1 loss - Stock Titan
ProKidney Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
ProKidney Announces Q2 2026 Financial Results Highlighting Increased Losses and R&D Spending - Kalkine Media
ProKidney Corp (PROK) Stock News Today - TradingKey
PROK Q1 2026 Earnings: Slight EPS Beat Signals Discipline as Clinical Pipeline Drives ValueOne-Time Gain Impact - vinanet.vn
ProKidney Corp. (PROK) director converts paired units into Class A stock - Stock Titan
3 Promising Penny Stocks With Market Caps Under $500M - simplywall.st
PROK Q2'26 Earnings: EPS estimate is (0.14) USD - TradingView
ProKidney (PROK) to Release Quarterly Earnings on Tuesday - marketbeat.com
ProKidney Corp. Revenue Breakdown – NASDAQ:PROK - TradingView
ProKidney Corp (PROK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ProKidney (PROK) Climbs 2.6% to $1.58 as Renal Biotech Tests Key Technical LevelsTriple Bottom - vinanet.vn
ProKidney Corp (PROK) Income Statement - TradingKey
ProKidney Corp (PROK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PROK|ProKidney Corp|Price:1.565|Chg%:+0.025 - TradingKey
ProKidney Corp (PROK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ProKidney Corp (PROK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ProKidney Corp (PROK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ProKidney Corp (PROK) Balance Sheet - TradingKey
ProKidney Corp (PROK) Cash Flow - TradingKey
PROK|ProKidney Corp|Price:1.504|Chg%:+0.004 - TradingKey
ProKidney Corp. (PROK) Q1 2026 Earnings: Narrower Loss as Clinical Pipeline AdvancesFiscal Year Earnings - dars.gov.et
ProKidney Corp (PROK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
0.86%
0.31%
자본화:
|
볼륨(24시간):